Strategic Development of Neural Stem & Progenitor Cell Products

Publisher Name :
Date: 15-Nov-2013
No. of pages: 141

This report is available at a flat 5% Discount on all license types till November 15, 2013. Listed above are original prices and the discount is applicable on the same.

Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny of stem cell division that normally undergo a limited number of replication cycles in vivo.

The terms neuronal and neural also need to be defined. Technically speaking, “neuronal” means “pertaining to neurons,” and “neural” means “pertaining to nerves, which are the cordlike bundles of fibers made up of neurons.” Since both terms ultimately are descriptive of neurons, the scientific community uses the terms “neuronal” and “neural” interchangeably. The complexity of this issue is explored from a strategic perspective within this report.

In particular, when naming products, companies are advised to use the term “neural” rather than “neuronal,” both in reference to stem cells and progenitor cells, in order to best position products within the marketplace. Also of interest is that when “stem cell” versus “progenitor cell” publications are compared, neural/neuronal “stem cell” publication rates continue to outpace neural/neuronal “progenitor cell” publications by over 200% over a trailing two-year period.

In summary, an understanding of neural stem cell language and terminology can substantially improve product naming, strategic positioning, and the effectiveness of marketing communications. These subtleties as explored in detail within the context of this industry report.

In addition, the report focuses on: recent advances in neural stem cell research applications; research priorities by market segment; opportunities for profitable product and technology development; the competitive environment for NSC products; detailed market size analysis; market trends and metrics; five-year projections; and the needs and decision-making of NSC scientists.

Market Segments

To facilitate research resulting from these advances, a large and diverse market has emerged for neural stem cell products, platforms, and technologies. In total, the neural stem cell product marketplace is comprised of the global sales of these items. One thriving component of this marketplace is the segment of companies that sell NSC research products to scientists.

Termed “research supply companies” or “research product vendors,” large companies selling neural stem cell research products include EMD Millipore, Life Technologies, Thermo Fisher Scientific, and STEMCELL Technologies, as well as more than 40 other suppliers that range in size from multinational corporations to small specialty companies. Together, these research supply companies represent a substantial annual percentage of NSC product sales. Each of these industry participants are identified within the context of this report. As of 2013, EMD Millipore, known as Merck Millipore outside of the United States and Canada, is the leader in neural stem cell product development for the scientific community. A Canadian company, STEMCELL Technologies, is a close second in the area of NSC product development for scientists.

Within this report, profitable opportunities for NSC research product development are revealed. Specifically, competitors looking to enter the NSC research products marketplace would do well to focus their energy on the areas considered highest priority by the scientific community, specifically cell-based therapies and standardized neurotoxicity assays. Due to recent legislative initiatives, interest in the latter is expected to increase significantly in the next several years. Furthermore, companies looking to enter the NSC product market could also focus their efforts on areas in which available products are not yet optimized for use with rat or mouse neural stem cells. Or, research supply companies could choose to focus product development on areas where human neural stem cell products are not yet available, although there would be some necessary work-around due to patent restrictions. Companies could also develop products for which there is little market competition, such as hESC-derived neural progenitors, kits for analysis of NSC differentiated progeny, NSC blotting and nucleofaction kits, and PCR arrays. Finally, companies could choose to explore varied sources from which to potentially derive neural stem cell products, such as human umbilical cord blood and derivatives of neural rosette cell lines.

In addition, pharmaceutical companies also have intense interest in neural stem cell product development. Because of their plasticity, ability to develop into the main phenotypes of the nervous system, and unlimited capacity for self-renewal, NSCs have been proposed for use in a variety of pharmaceutical applications, including:

  • Neurotoxicity testing
  • Cellular therapies to treat central nervous system (CNS) conditions
  • Neural tissue engineering and repair
  • Drug target validation and testing
  • Personalized medicine
  • And more

While development of therapies that involve embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs) continue to expand, development of neural stem cell therapies has been more substantially affected by barriers to entry, including patent restrictions, the dominance of current competitors, and the complexity of neural stem cell applications. Nonetheless, within the area of NSC therapy development, there are currently three dominant competitors, which are Neural Stem, NeuroNova AB, and NeuroGeneration. In addition to those companies, there are also more than a dozen other companies actively developing NSC therapies for use in the treatment of human injury and disease.

For this reason, development of NSC products by the pharmaceutical sector also represents a thriving segment of the global NSC product marketplace. Of particular interest to this community is the potential for use of NSCs to heal tissues that have a naturally limited capacity for renewal, such human brain and spinal cord tissues.

Furthermore, within the pharmaceutical sector, development of new drugs is extremely costly and the success rate of bringing new compounds to the market is unpredictable. Therefore, it is crucial that pharmaceutical companies minimize late-stage product failures, such as suboptimal pharmacokinetic properties or unexpected neurotoxicity effects, that can can arise when candidate drugs enter the clinical testing stages. To achieve this, it would be highly desirable to test candidate drugs using in vitro assays of high human relevance as early as possible. Because NSCs have the potential to differentiate into nearly all of the main phenotypes of the nervous system, they represent an ideal cell type from which to design such neural screening assays.

In summary, the unifying factor within the NSC product marketplace is that all companies involved need to understand market forces, trends, metrics, and financials, in order to out-compete the competition and make more profitable decisions. Producing NSC products can involve complicated and confusing decisions, but it doesn’t have to.

Claim this report to reveal the current and future needs of the NSC marketplace, so you can focus your marketing efforts on the most profitable products, in the most promising research areas, and within the most lucrative domestic and international markets. Your competitors would prefer you didn’t buy this report. But when you do, you’ll be gaining invaluable stem cell market insights to help you control and dominate this market.

Methods and Methodology

As a technology company, BioInformant’s standard techniques derive market data from sources that utilize high-quality primary research inputs. The following constitute the basis for our research and analysis:

  • Preliminary Research – Examination of studies that need further confirmation by the scientific community, using extensive secondary research.
  • Fill-gap Research – Selectively sampled and focused primary research as a fill-gap strategy.
  • Historic Analysis – Historic analysis of all end-user industries/markets, requiring technology and market evaluations, growth projections, and market size estimation of end-user markets.
  • Historic Supply Chain/Raw Materials Analysis – Comprehensive analysis of data for each primary market segment.
  • Data Consolidation – Merging historic end-user market data to yield consolidated primary market data.
  • Cross Linking – Primary market data (historic) is compared with resulting end-user consolidated market data and the variance in percentages between data sets is calculated by year.
  • Variance Determination – A median figure for each year with a tolerance range equal to twice the variance percentage is determined.
  • Projections – End-user markets are projected forward (typically 2013-17) based upon historic growth, technology and market trends, and primary research from the market place.
  • Variance Factorization – Consolidation of projected end-user market data to yield derived primary market data. The data is adjusted to the historic variance determinations, as above. The resulting data is further verified by confirmatory primary research.
  • Confirmatory Primary Research – Resulting data is presented from companies or individuals participating as research partners. Variations from derived data are adjusted to reflect primary research based consensus.
  • Electronically Based End-User Surveys – In addition to the methods described above, electronically based end-user surveys are utilized. Surveys are distributed to a comprehensive panel of academic and industry representatives working within the market segment of interest.

Furthermore, the market intelligence contained in this report was compiled using a broad range of sources, including:

  • Grant Funding Databases (NIH database, DoD database, and more)
  • Patent Databases (USPTO, WIPO)
  • Scientific Publication Databases (PubMed, Highwire Press, Google Scholar)
  • Product Launch Announcements (Trade Journals, Company Websites, PR News Feeds)
  • Financial Data (SEC Filings, Investor Relations Packets)
  • International Surveys (Electronically Distributed End-User Surveys)
  • And More

Finally, a rare and valuable feature of this report is an end-user survey of 240 researchers (91 U.S. / 149 International) that identify neural stem cell research as their core research focus. These findings reveal NSC researcher needs, technical preferences, key factors influencing buying decisions, and more.

Scientist survey results include:

  • Emerging trends within the NSC research sector
  • Insights into NSC product selection, purchasing decisions, and preferred providers
  • Crucial trends and unmet market needs within the NSC marketplace
  • “Tested Sentences” for selling to NSC scientists
  • Breakdown of the marketing methods used by industry participants
  • And much more

Leverage these insider insights to make effective product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates.

Conclusions

In summary, growth in stem cell research has exploded over the past two decades, and so the market to supply NSC products and technologies has grown to meet this huge demand. The proliferation of neural stem cell research since 1992 has opened the floodgates for forward-thinking companies to enter a unique product and technology marketplace. Neural stem and progenitor cells are the keys with which researchers are unlocking some of the most destructive human diseases and the cells’ future potential is bright.

Key Findings Include:

  • Charts, Trends, and Metrics for the NSC Product Market
  • Analysis NSC Grant Rates, Scientific Publication Rates, and Patent Rates
  • Market Size Quantification for NSC Products
  • 5-Year Market Size Projections (2013-2017) for NSC Products
  • Profitable Opportunities for NSC Product and Technology Development
  • Consumer Behavioral Patterns and Preferred Providers
  • Preferred Species for NSC Research
  • Crucial Trends and Unmet Market Needs
  • End-User Survey of NSC Researchers (91 U.S. / 149 International)

Strategic Development of Neural Stem & Progenitor Cell Products

Table Of Contents

I. Background
A. Language and Definitions
1. Neurogenesis
2. Neuronal vs. Neural
3. Neural Stem Cells vs. Neural Progenitor Cells
B. Brief History
C. Regulation of Neural Stem & Progenitor Cells
1. In vitro Regulation
2. In vivo Regulation
D. Product Background

II. Applications
A. Basic Research
1. Developmental Biology
2. Adult Biology
B. Drug Discovery Applications
C. Drug Delivery Applications
D. Neural Toxicology Assessment
E. Neural Transplantation
F. Brain Tumor Research

III. Application Priorities
A. Overall
1. Cell-Based Therapies
2. Standardized Neural Toxicology Assays
B. Breakdown of Neural Stem Cell Research by Disorder
C. By Segment
1. Academic
2. Biotech
3. Pharma

IV. Patents
A. Key Neural Stem and Progenitor Cell Patents
B. Additional US Patents
C  Additional European Patents

V. Market Trend Analysis
A. Clinical Trial Analysis
1. Frequency by Year
2. Geographical Breakdown
B. Grant Rate Analysis
1. Historical Analysis
2. Future 5-Year Projection
C. Patent Rate Analysis
D. Scientific Publication Rate Analysis
1. Historical Data
2. Future 5-Year Projections
3. NSC Research Frequency Relative to Other Stem Cell Types
E. Geographical Analysis: Domestic vs. International Status
1. Number of NSC Labs, by Region of World
2. Percent of Total NSC-Specific Research Funding, by Region of World

VI. Market Size
A. Definition: NSC Product Market
B. Experimental Approach
C. NSC Research Products
1. Market Size
2. 5-Year Market Projections
D. NSC Therapy Market
1. Market Size
2. 5-Year Market Projections

VII. Competitors: Leading Suppliers Of Neural Stem Cell Products
A.  EMD Millipore
B.  STEMCELL Technologies
C.  AlphaGenix, Inc.
D.  R&D Systems
E.  Cell Applications
F.  SA Biosciences
G.  ScienCell
H.  Neuromics
I.  Amaxa
J.  Life Technologies
K.  Sigma Aldrich
L.  StemCells, Inc.
M.  Lonza
N.  BD Biosciences

VIII. Leading Pharmaceutical Companies Developing Neural STEM Cell Therapies
A. Neuralstem, Inc
B. NeuroNova AB
C. NeuroGeneration

IX. Breakdown Of Stem Cell Research Activity By Cell Type

X. Potential End-Users Of Neural Stem Cell Products
A. Academic Labs
B. Private Labs
C. Commercial Labs
D. Government Labs

XI. Product Ideas & Suggestions
A. Product Categories
1. Neural Stem Cell Lines & Neural Tissues
2. Neural Stem Cell Kits
3. Media: Maintenance, Differentiation, Expansion, & Freezing Medium
4. Growth Factors
5. Markers for Neural Stem Cells & Differentiated Progeny
6. PCR Arrays
7. Nucleofection Tools
8. Neural Toxicity Assessment
B. Product Suggestions
1. Neural Toxicity Assessment Products
2. Species-Specific Opportunities
3. Areas of Underdeveloped Competition
4. NSCs Derived from Novel Sources
5. Novelty Cells Types, such as Neural Rosette Cells (R-NSCs)

XII. Scientist Panel: Detailed End-User Survey
A. Survey Overview
B. Characterization of Market Survey Respondents
1. Geographic Distribution of Respondents
2. Respondent Breakdown by Industry Affiliation
3. Breakdown of Respondents by Duration of NSC Research Activity
C. Survey Findings
1. General Scope
2. Comparison of Providers / Brand Preferences
3. Marketing Assessment
D. Terms Used in Online Product Search

XIII. Conclusions

  • Global Dental Implants Market Driven by Demand in Cosmetic Dentistry
    The global market for dental implants has been witnessing steady growth in the last couple of years due to increased demand for cosmetic dentistry and rise in incidences of dental disorders. People’s awareness about aesthetic dentistry procedures has increased in recent years, which is also fueling the growth of the dental implant market. With economic [...]
  • Air Traffic Management and Control Market Driven by Technological Advancement
    The global market for air traffic management and control has grown steadily in the last couple of years with increase in air traffic volume and congestion. Air Traffic Control (ATC) consists of an elaborate system of ground stations, radar arrays and professional air traffic controllers. With increase in air travel for business and leisure, as [...]
  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • ImmunNovative Developments SL – Product Pipeline Review – 2014
    Published: 24-Nov-2014        Price: US $1500 Onwards        Pages: 18
    Global Markets Direct's, ‘ImmunNovative Developments SL Product Pipeline Review 2014', provides an overview of the ImmunNovative Developments SL's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of ImmunNovative Developments SL's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.......
  • LivTech, Inc. – Product Pipeline Review – 2014
    Published: 24-Nov-2014        Price: US $1500 Onwards        Pages: 17
    Global Markets Direct's, ‘LivTech, Inc. Product Pipeline Review 2014', provides an overview of the LivTech, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of LivTech, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured ne......
  • Neuroptis Biotech – Product Pipeline Review – 2014
    Published: 24-Nov-2014        Price: US $1500 Onwards        Pages: 22
    Global Markets Direct's, ‘Neuroptis Biotech Product Pipeline Review 2014', provides an overview of the Neuroptis Biotech's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Neuroptis Biotech's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and......
  • Avipep Pty Ltd – Product Pipeline Review – 2014
    Published: 24-Nov-2014        Price: US $1500 Onwards        Pages: 20
    Global Markets Direct's, ‘Avipep Pty Ltd Product Pipeline Review 2014', provides an overview of the Avipep Pty Ltd's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Avipep Pty Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured......
  • Oncobiologics, Inc. – Product Pipeline Review – 2014
    Published: 24-Nov-2014        Price: US $1500 Onwards        Pages: 26
    Global Markets Direct's, ‘Oncobiologics, Inc. Product Pipeline Review 2014', provides an overview of the Oncobiologics, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Oncobiologics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest update......
  • BeiGene (Beijing) Co., Ltd – Product Pipeline Review – 2014
    Published: 24-Nov-2014        Price: US $1500 Onwards        Pages: 35
    Global Markets Direct's, ‘BeiGene (Beijing) Co., Ltd Product Pipeline Review 2014', provides an overview of the BeiGene (Beijing) Co., Ltd's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of BeiGene (Beijing) Co., Ltd's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also ......
  • OrphageniX, Inc. – Product Pipeline Review – 2014
    Published: 24-Nov-2014        Price: US $1500 Onwards        Pages: 17
    Global Markets Direct's, ‘OrphageniX, Inc. Product Pipeline Review 2014', provides an overview of the OrphageniX, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of OrphageniX, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and fe......
  • Biosceptre International Limited – Product Pipeline Review – 2014
    Published: 24-Nov-2014        Price: US $1500 Onwards        Pages: 21
    Global Markets Direct's, ‘Biosceptre International Limited Product Pipeline Review 2014', provides an overview of the Biosceptre International Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Biosceptre International Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molec......
  • SYNIMMUNE GmbH – Product Pipeline Review – 2014
    Published: 24-Nov-2014        Price: US $1500 Onwards        Pages: 18
    Global Markets Direct's, ‘SYNIMMUNE GmbH Product Pipeline Review 2014', provides an overview of the SYNIMMUNE GmbH's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of SYNIMMUNE GmbH's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs